Hyaluronic Acid Gels Crosslinked By Sodium Trimetaphosphate

Patent No. EP2994090 (titled "Hyaluronic Acid Gels Crosslinked By Sodium Trimetaphosphate") was filed by Allergan Industrie on May 8, 2013. The application was issued on Dec 6, 2017.

Patent Summary

Patent Family

Patent Family

Patent Oppositions

Patent oppositions filed by competitors challenge the validity of a granted patent. These oppositions are typically based on claims of prior art, lack of novelty, or non-obviousness. They are a key part of the process for determining a patent's strength and enforceability.

CompanyOpposition DateRepresentative
LABORATOIRES VIVACYSep 5, 2018TRIPOZ

Dossier Documents

The dossier documents provide a comprehensive record of the patent's prosecution history - including filings, correspondence, and decisions made by patent offices - and are crucial for understanding the patent's legal journey and any challenges it may have faced during examination.

  • Date

    Description

  • Get instant alerts for new documents

EP2994090

ALLERGAN INDUSTRIE
Application Number
EP13752667A
Filing Date
May 8, 2013
Status
Opposition Rejected
Dec 22, 2023
Publication Date
Dec 6, 2017